{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:18:24Z","timestamp":1718237904938},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1097\/mbc.0000000000000472","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T05:32:41Z","timestamp":1449811961000},"page":"822-824","source":"Crossref","is-referenced-by-count":0,"title":["Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab"],"prefix":"10.1097","volume":"27","author":[{"given":"Elie El","family":"Rassy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Tabchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady G.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Chebib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hampig R.","family":"Kourie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2516.2005.01136.x","article-title":"Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies","volume":"11","author":"Holme","year":"2005","journal-title":"Haemophilia"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2141.1993.tb03343.x","article-title":"Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V","volume":"85","author":"B\u00e4nninger","year":"1993","journal-title":"Br J Haematol"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-111-8-631","article-title":"Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery","volume":"111","author":"Flaherty","year":"1989","journal-title":"Ann Intern Med"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ajh.2830450206","article-title":"Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis","volume":"45","author":"Ortel","year":"1994","journal-title":"Am J Hematol"},{"key":"R5-14-20210203","first-page":"847","article-title":"Interference with fibrin formation in multiple myeloma by an unusual protein found in blood and urine","volume":"42","author":"Craddock","year":"1953","journal-title":"J Lab Clin Med"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/ajcp\/25.11.1263","article-title":"Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma","volume":"25","author":"Frick","year":"1955","journal-title":"Am J Clin Pathol"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.2830250109","article-title":"Spontaneous antithrombin in a patient with benign paraprotein","volume":"25","author":"Gabriel","year":"1987","journal-title":"Am J Hematol"},{"key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood.V35.5.695.695","article-title":"Hemostatic defects in dysproteinemias","volume":"35","author":"Perkins","year":"1970","journal-title":"Blood"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.2005.05894.x","article-title":"Autoantibodies to thrombin directed against both of its cryptic exosites","volume":"132","author":"Mollica","year":"2006","journal-title":"Br J Haematol"},{"key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood.V72.4.1375.1375","article-title":"Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves","volume":"72","author":"Stricker","year":"1988","journal-title":"Blood"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.V76.11.2249.2249","article-title":"Isolation and characterization of an acquired antithrombin antibody","volume":"76","author":"Lawson","year":"1990","journal-title":"Blood"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-939557","article-title":"Mechanism of action of factor VIIa in the treatment of coagulopathies","volume":"32","author":"Hedner","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R13-14-20210203","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2002-03-0765","article-title":"Rituximab in the treatment of acquired factor VIII inhibitors","volume":"100","author":"Wiestner","year":"2002","journal-title":"Blood"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2003-11-4075","article-title":"Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia","volume":"103","author":"Stasi","year":"2004","journal-title":"Blood"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"R16-14-20210203","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.22019","article-title":"Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis","volume":"54","author":"Roll","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R17-14-20210203","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2141.2004.04889.x","article-title":"The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura","volume":"125","author":"Cooper","year":"2004","journal-title":"Br J Haematol"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T23:56:40Z","timestamp":1718236600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201610000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000472","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}